Company Active LTD

Company profile

Health Companion Limited

Health Fabric

Health Companion Limited is a UK company with status active founded in 2015.

CRN
09727651
Founded
2015
Age
10

Overview

Legal name
HEALTH COMPANION LIMITED
Region
Unknown
Registered address
1190A-1194 STRATFORD ROAD
HALL GREEN
BIRMINGHAM
ENGLAND
B28 8AB
Insolvency history
No

Latest accounts

Financial period: 1 Sep 2023 to 31 Aug 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
4

Company events

Reference milestones and recent Companies House filing stream events.

6 events
17 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Aug
2026

Accounts due

Accounts Due

Next accounts due date

10 Apr
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzUxNTM2MDUxMGFkaXF6a2N4

Published 10 Apr 2026 10:38

03 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Aug
2024

Accounts filed

Accounts

Last accounts made up date

11 Aug
2015

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2020
Funded years
2020, 2021, 2022
Age at first award
5 years

Projects

2022 Collaborative R&D Lead participant

Reducing Health inequalities and enabling self care for all

1 May 2022 to 31 Mar 2024

Awarded
£465,620
Total cost £665,172

The NHS Race and Health observatory recently highlighted ethnic inequalities in the UK. Examples included that 24% of all deaths in England and Wales in 2019 that were caused by cardio vascular disease were in black and ethnic groups. Also South Asians have a 40% higher death rate from CHD than the general population, and south Asian and black people are ...

2021 Collaborative R&D Lead participant

AI enabled self management to address health inequalities

1 Mar 2021 to 30 Nov 2021

Awarded
£174,466
Total cost £174,466

Early during the COVID-19 pandemic, it became clear that people with multiple conditions such as heart disease, chronic respiratory disease, diabetes, cancer and high blood pressure are particularly clinically vulnerable to COVID 19\. What has also now become clear is that people of British Black, Asian, and minority ethnic (BAME) origin are at a higher l...

2020 Collaborative R&D Lead participant

Enabling Self Management for COVID 19 high risk groups

1 Dec 2020 to 28 Feb 2021

Awarded
£62,000
Total cost £78,750

Early during the COVID-19 pandemic, it became clear that people with multiple conditions such as heart disease, chronic respiratory disease, diabetes, cancer and high blood pressure are particularly clinically vulnerable to COVID 19\. What has also now become clear is that people of British Black, Asian, and minority ethnic (BAME) origin are at a higher l...

Product types

Collaborative R&D